JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 1 filers reported holding JANUX THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181 | +178.5% | 17,922 | +227.1% | 0.00% | – |
| Q2 2023 | $65 | -39.8% | 5,479 | -38.5% | 0.00% | – |
| Q1 2023 | $108 | +77.0% | 8,904 | +93.2% | 0.00% | – |
| Q4 2022 | $61 | -99.4% | 4,608 | +533.0% | 0.00% | – |
| Q3 2022 | $10,000 | -9.1% | 728 | -15.3% | 0.00% | – |
| Q2 2022 | $11,000 | -73.8% | 860 | -70.8% | 0.00% | – |
| Q1 2022 | $42,000 | – | 2,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $216,333,000 | 3.47% |
| 5AM Venture Management, LLC | 446,266 | $11,134,000 | 2.80% |
| Samsara BioCapital, LLC | 607,949 | $15,168,000 | 1.87% |
| EcoR1 Capital, LLC | 1,411,975 | $35,229,000 | 1.32% |
| Logos Global Management LP | 547,122 | $13,651,000 | 1.15% |
| BVF INC/IL | 1,176,681 | $29,358,000 | 1.10% |
| Orbimed Advisors | 3,466,386 | $86,486,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 700,000 | $17,465,000 | 0.31% |
| Pinz Capital Management, LP | 32,100 | $801,000 | 0.24% |
| Woodline Partners LP | 334,260 | $8,340,000 | 0.16% |